Ubrelvy Copay Card & Savings Guide: 2026
Ubrelvy (ubrogepant) treats a migraine after it starts, and without coverage a handful of tablets can cost more than $100 apiece — brutal math for a drug you take precisely when life is already stopped. The manufacturer’s card is one of the most generous in this guide series: a genuine $0 best case with a $7,000 annual ceiling. The catches are all in the eligibility lines and the insurance hurdles that come before the card — this guide covers both, plus the assistance program that covers people the card legally can’t.
What you’ll pay with the Ubrelvy copay card
With the Ubrelvy coupon — the official savings card — eligible patients pay as little as $0 per fill, with the card contributing up to $7,000 per calendar year across up to 13 fills. [1] That cap is high enough that most commercially insured patients genuinely see $0 all year. Where the math gets worse:
- High-deductible plans, early in the year: before your deductible is met, the claim can price at the drug’s full cost; the card pays its per-fill share and you may owe a balance until your deductible fills. It self-corrects as the year progresses — don’t conclude in February that “the card doesn’t work.”
- Accumulator programs: some plans accept the card’s payments without counting them toward your deductible or out-of-pocket maximum. One question to your plan — “do manufacturer copay payments count toward my deductible?” — tells you whether the card is solving each month or also building your year.
Enrolling takes minutes: the official Ubrelvy site runs a short eligibility screen, issues the card digitally, and it applies at the pharmacy register alongside your insurance. Re-enroll each calendar year — set the January reminder now.
Who qualifies
- Commercial insurance (employer or private) with a valid Ubrelvy prescription, age 18+, U.S. resident.
- Excluded: Medicare (including Part D), Medicaid, TRICARE, VA, and any other government-funded plan — federal anti-kickback rules, not AbbVie policy. If that’s you, don’t pay list out of frustration: the assistance program below exists for exactly this gap, and Medicare Part D’s redesigned out-of-pocket cap has also softened the worst-case math for covered fills.
Ubrelvy patient assistance: myAbbVie Assist
AbbVie’s patient assistance program, myAbbVie Assist, provides Ubrelvy free of charge to qualifying patients with limited or no insurance coverage. [2] Three things worth knowing:
- One application covers both Ubrelvy and Qulipta — directly relevant if your clinician has you on acute treatment and prevention together, which is increasingly standard for frequent migraine.
- Expect income documentation (tax return or pay stubs) and a prescriber section; processing typically runs a few weeks, and approvals last a year before renewal. Income eligibility reaches up to about 600% of the Federal Poverty Level — the industry’s most generous (roughly $90,000 a year for a single person) — and significant medical expenses can qualify people above it. [2]
- Bridge the gap while an application processes: ask your prescriber about samples — neurology offices commonly stock CGRP-class samples, and it’s a routine ask, not a favor.
Application mechanics, common rejection reasons, and how to restart a stalled application: our patient assistance guide.
Getting your plan to cover it in the first place
The card can only discount a covered claim, and Ubrelvy’s usual coverage hurdles are predictable:
Step therapy — “try triptans first.” Triptans (sumatriptan, rizatriptan) are genuinely effective for many people and cost a few dollars generic, so nearly every plan requires them first. What wins the prior authorization or its appeal is documentation that steps are complete or inappropriate:
- Triptan failure: two triptans tried without adequate relief is the standard bar — make sure your chart names them and the outcomes.
- Intolerable side effects count as failure — chest tightness, sedation, “triptan hangover” — if they’re documented.
- Cardiovascular contraindications: triptans constrict blood vessels and are avoided with coronary disease, uncontrolled hypertension, prior stroke, and certain migraine subtypes. For these patients, CGRP-class drugs like Ubrelvy are the guideline-supported first choice — an appeal letter saying exactly that, with the diagnosis attached, is close to a skeleton key.
Ubrelvy quantity limits. Plans commonly cap fills at 10–16 tablets/month. Ubrelvy’s dosing allows a second tablet 2+ hours after the first, so a bad month burns tablets fast. A quantity-limit exception documenting your monthly migraine days and the two-dose pattern raises the cap; a migraine diary is the cheapest, most persuasive exhibit you can attach.
The bigger Ubrelvy cost lever: acute + preventive math
If you’re consistently bumping quantity limits or treating more than about four migraines a month, the economics — and the guidelines — both point the same direction: prevention. Qulipta, Ubrelvy’s preventive sibling, runs its own savings card and shares the assistance application; effective prevention that cuts your attack count in half also halves your acute-tablet burn, your plan’s quantity-limit friction, and the number of days migraine owns. That’s a clinical decision, not a coupon decision — but bring the full cost picture into the appointment, because “I’m rationing my abortive tablets” is precisely the sentence that changes treatment plans.
Frequently Asked Questions
How much is Ubrelvy with the copay card?
Eligible commercially insured patients can pay as little as $0 per fill with the Ubrelvy savings card, with a maximum benefit of $7,000 per calendar year across up to 13 fills.
Can I use the Ubrelvy card on Medicare?
No — Medicare, Medicaid, TRICARE, and other government programs are excluded by federal rules. Uninsured and underinsured patients may qualify for free medication through myAbbVie Assist instead.
Is there a card that covers both Ubrelvy and Qulipta?
They’re both AbbVie migraine drugs but run separate savings cards — one for acute treatment (Ubrelvy), one for prevention (Qulipta). If you take both, enroll in both; the assistance program (myAbbVie Assist) covers the two under one application.
Why does my insurance make me try triptans before Ubrelvy?
Step therapy: triptans are effective for many people and cost a few dollars generic, so plans require trying them first. Documented triptan failure, intolerable side effects, or cardiovascular contraindications are exactly what wins the prior authorization or its appeal.
What if I need more Ubrelvy tablets than my plan allows?
Quantity limits (often 10–16 tablets/month) can be raised through a quantity-limit exception documenting your migraine frequency and the two-dose treatment pattern. If you’re consistently near the cap, that’s also the clinical signal to discuss adding a preventive like Qulipta.
Sources
This guide covers cost and access, not medical advice — talk to your prescriber before changing how you take Ubrelvy. Program terms, prices, and eligibility change without notice; confirm current details with the official program (linked in the sources above) before relying on them. We’re an independent publisher, not affiliated with or endorsed by AbbVie — see our full medical disclaimer.